Please login to the form below

Not currently logged in
Email:
Password:

neglected tropical diseases

This page shows the latest neglected tropical diseases news and features for those working in and with pharma, biotech and healthcare.

Novartis’ Egatan gains US approval for neglected tropical disease

Novartis’ Egatan gains US approval for neglected tropical disease

US approval removes barrier to greater access. The FDA has given its seal of approval to Novartis’ Egatan, which becomes the first approved treatment in the US for tropical disease fascioliasis. ... said Dr Mwelecela Malecela, Director of the

Latest news

  • The power of pharma businesses to drive social change The power of pharma businesses to drive social change

    For example, we have a focus on, and commitment to, combatting neglected tropical diseases (NTDs). ... Our research teams are collaborating with peers from organisations around the world to help in the development of effective treatments for diseases

  • GSK tops pharma access to medicines table GSK tops pharma access to medicines table

    drive to tackle neglected tropical diseases," commented ATMI founder and chief executive Wim Leereveld. ... the pipeline tackling diseases affecting developing countries to 327 at last count.

  • Video for neglected tropical diseases challenges viewers Video for neglected tropical diseases challenges viewers

    The seven diseases represent 90 per cent of the total global neglected tropical disease (NTD) burden. ... In 2012 the World Health Organization issued its Accelerating Work to Overcome the Global Impact of Neglected Tropical Diseases roadmap for tackling

  • Takeda buys vaccines specialist Inviragen Takeda buys vaccines specialist Inviragen

    Its lead candidate is DENVax, a four-strain recombinant viral vaccine for the prevention of dengue infection – the most widespread tropical disease after malaria. ... The acquisition also gives Takeda scope to tackle neglected tropical diseases, which

  • Pharma companies partner with Japanese government Pharma companies partner with Japanese government

    research funding that will help tackle HIV, malaria, tuberculosis and neglected tropical diseases (NTDs). ... related to access to medicines in order to effectively combat infectious diseases, including neglected tropical diseases.”.

More from news
Approximately 3 fully matching, plus 11 partially matching documents found.

Latest Intelligence

  • Reaching new heights Reaching new heights

    The seemingly intractable problems of neglected tropical diseases, compounded by poverty and war in Africa, finally appear to be responding to philanthropy-funded research and engagement, resulting in fundamental changes by ... biologics. Patients will

  • Pharma deals in August 2015 Pharma deals in August 2015

    $65m. Antisense oligonucleotides target RNA and the new collaboration will extend into renal diseases, cardiovascular and metabolic fields. ... Introduced by the FDA in 2007, a priority review voucher (PRV) is an incentive for companies to invest in

  • Pharma deals during November 2014 Pharma deals during November 2014

    from ten months down to six). Introduced by the FDA in 2007, a PRV is an incentive for companies to invest in treatments for neglected tropical diseases. One of 16 tropical ... diseases that qualify is leishmaniasis, for which Knight's Impavido

  • Interview: Charles Mgone, EDCTP Interview: Charles Mgone, EDCTP

    We will ask them what areas they are interested in regarding our scope in HIV, TB, malaria and now neglected tropical diseases.”. ... It is all looking very positive.”. Mgone explains that EDCTP is expanding its remit to include neglected infectious

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Complete Medical Communications (CMC)

CMC is a leading global agency dedicated to healthcare communications across the lifecycle. We combine scientific acumen, excellence in delivery...

Latest intelligence

Five key trends in precision and personalised healthcare
Here, we deep dive into five of the key trends in precision medicine and personalised healthcare to explore how the healthcare industry is changing and how pharmaceutical and biotech companies...
OPEN Health Graduate Programme: from OPEN VIE to OPEN Health Medical Communications
Isobel Owens shares her experience of the OPEN Health Graduate Programme from OPEN VIE to OPEN Health Medical Communications...
Language barriers: Obesity has become a loaded word
...

Infographics